Skip to content

Clinical trials

Phase 4 Hemorrhage trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 4 Country / region: Switzerland Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20121
20141
20191
20201
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insel Gruppe AG, University Hospital Bern2
University of Zurich2
Christian Haslinger1
Drahomir Aujesky1
Triemli Hospital1
University Children's Hospital, Zurich1
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage9
Blood Loss, Surgical2
Blood Coagulation Disorders1
Cardiovascular Diseases1
Coronary Artery Disease1
Embolism1
Embolism and Thrombosis1
Hemostatic Disorders1
Lung Diseases1
Postoperative Hemorrhage1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.